264194-31-2

Basic information

• Product Name: Benzenamine, 3-(difluoromethoxy)-4-methyl- (9CI)
• Synonyms: Benzenamine, 3-(difluoromethoxy)-4-methyl- (9CI);BenzenaMine, 3-(difluoroMethoxy)-4-Methyl-
• CAS NO: 264194-31-2
• Molecular Formula: C8H9F2NO
• Molecular Weight: 173.1599664
• Product Categories: METHOXY
• Mol File: 264194-31-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 240.2±35.0 °C(Predicted)
• Appearance: /
• Density: 1.208±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 4.08±0.10(Predicted)
• CAS DataBase Reference: Benzenamine, 3-(difluoromethoxy)-4-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 3-(difluoromethoxy)-4-methyl- (9CI)(264194-31-2)
• EPA Substance Registry System: Benzenamine, 3-(difluoromethoxy)-4-methyl- (9CI)(264194-31-2)

Safety Data

• Hazardous Substances Data: 264194-31-2(Hazardous Substances Data)

Usage

General Description

Benzenamine, 3-(difluoromethoxy)-4-methyl- (9CI) is a chemical compound with the molecular formula C8H10F2NO. It is also known by its CAS number 874125-50-5. This chemical is a substituted aniline derivative, which means it contains a benzene ring with an amino group (NH2) attached to it. In this specific compound, there is also a difluoromethoxy group and a methyl group attached to the benzene ring. This chemical may be used in various pharmaceutical or research applications due to its unique structure and potential reactivity. It is important to handle this compound with care and adhere to proper safety protocols when working with it.

Upstream product

• 5428-54-6 2-methyl-5-nitrophenol 

Relevant articles and documents

ISOINDOLINONE COMPOUNDS

Disclosed herein is a compound or pharmaceutically acceptable salts or stereoisomers thereof of of formula I wherein X1 is linear or branched C1-6 alkyl, C3-6 cycloalkyl, -C1-6 alkyl C3-6 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, C1-6 alkyl C6-10 aryl, C1-6 alkyl 5-10 membered heteroaryl, wherein X1 is unsubstituted or substituted with one or more of halogen, linear or branched C1-6 alkyl, linear or branched C1-6 heteroalkyl, CF3, CHF2, -O-CHF2, -O-(CH2)2-OMe, OCF3, C1-6 alkylamino, -CN, -N(H)C(O)-C1- 6alkyl, -OC(O)-C1-6alkyl, -OC(O)-C1-4alkylamino, -C(O)O-C1-6alkyl, -COOH, - CHO, -C1-6alkylC(O)OH, -C1-6alkylC(O)O-C1-6alkyl, NH2, C1-6 alkoxy or C1-6 alkylhydroxy; X2 is hydrogen, C6-10 aryl, 5-10 membered heteroaryl, -O-(5-10 membered heteroaryl), 4-8 membered heterocycloalkyl, C1-4 alkyl 4-8 membered heterocycloalkyl, -O-(4-8 membered heterocycloalkyl), -O-C1-4 alkyl-(4-8 membered heterocycloalkyl), -OC(O)-C1-4alkyl-4-8 membered heterocycloalkyl or C6 aryloxy, wherein X2 is unsubstituted or substituted with one or more of linear or branched C1-6 alkyl, NH2, NMe2 or 5-6 membered heterocycloalkyl; n is 0, 1 or 2.

CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS

The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.